Sievers H, Freund K, Eleflheriadis S, et al.Lung protection during total cardio puhnonary bypass by isolated lung perfusion:results of anovel perfusion Strategy[J].Ann Thorar Surg,2003,76(2):516.
[2]
Calvin S,Song W,Anthom P,et a1.Pulnmnary dysfunction after cardiac surgery[J].Chest,2002,121(4):1269.
[3]
Ambrosinig, Adidac, Altieridc. A novel and-apop tosis gene,survivin.Expressed in cancer and Lymphoma[J].Natmed,1997,3(8):917-921.
[4]
Sievers H,Freund K,Eleflheriadis S,et al. Lung protection during total cardiopuhnonary bypass by isolated lung perfusion:results of a novel perfusion strategy[J].Ann Thorar Surg,2003,76(2):5l6.
[5]
Finn AB, Morgan P. Effects of inhitbition of complementactivation using soluble complement receptor on neutrophil CD11/CD18 and L-selection expression and release of IL-8 and elastase in simulated cardiopulmonary bypass[J]. Thorac Cardiovasc Surg,1996,111:451-459.
[6]
Friedman M, Warg SY, Sellke FW, et al.Neutrophil adhesion blockade with NPC decrease pulmonary injury after total cardiopulmonary bypass[J]. Thorac Cardiovasc Surg,1999,111:460-468.
[7]
Lif,Altieridc. The cancer anti-apoptosis mouse surviving gene; characerization of Locus and transcriptional requirements of basal and cell-dependent expression[J].Cancer Res,1999,59(13):3143-3151.
[8]
Lacasseec,Bairds,Kdrnelukrg,et al.The inhibitors of apoptosis(IAPs)and their emerging role in cancer[J].Oncogene,1998,17(25):3247-3259.
[9]
Hirotaka,Isober,Kenji okajima,et al.Inhibition of tumor necrosis factorproduction by urinary trypsin inbibitor[J].International Congress Series, 2003(1225):69-74.
